Radiotherapy in the management of lung oligometastases

被引：0

作者：

Bourbonne, V. ^{[1
,2
]}

Levy, A. ^{[3
,4
]}

Khalifa, J. ^{[5
]}

Antoni, D. ^{[6
]}

Blais, E. ^{[7
]}

Darreon, J. ^{[8
]}

Le Pechoux, C. ^{[3
,4
]}

Lerouge, D. ^{[9
]}

Giraud, P. ^{[10
,11
]}

Marguerit, A. ^{[12
]}

Pourel, N. ^{[13
]}

Riet, F. -g. ^{[14
]}

Thureau, S. ^{[15
,16
]}

机构：

[1] CHU Brest, Radiat Oncol Dept, Brest, France

[2] Univ Bretagne Occidentale, LaTim, Inserm, UMR 1101, Brest, France

[3] Ctr Int Canc Thorac CICT, Dept Radiat Oncol, Gustave Roussy, F-94805 Villejuif, France

[4] Univ Paris Saclay, Fac Med, F-94270 Le Kremlin Bicetre, France

[5] Inst Claudius Regaud, Inst Univ Canc Toulouse Oncopole, Dept Radiat Oncol, Toulouse, France

[6] Inst Cancerol Strasbourg Europe, Inst Claudius Regaud, Toulouse, France

[7] Inst Cancerol Strasbourg Europe, Dept Radiat Oncol, Strasbourg, France

[8] Polyclin Marzet, Dept Radiat Oncol, Pau, France

[9] Ctr Francois Baclesse, Dept Radiat Oncol, Caen, France

[10] Hop Europeen Georges Pompidou, Ctr Francois Baclesse, Paris, France

[11] Univ Paris Cite, Paris, France

[12] Inst Cancerol Montpellier, Paris, France

[13] Inst St Catherine, Dept Radiat Oncol, Avignon, France

[14] Ctr Hosp Pr St Gregoire, Dept Radiat Oncol, F-35760 St Gregoire, France

[15] Ctr Henri Becquerel, Radiotherapy Dept, Rouen, France

[16] Univ Rouen, QuantIF Litis EA4108, Rouen, France

来源：

CANCER RADIOTHERAPIE | 2024年 / 28卷 / 01期

关键词：

Oligometastasis; Lung; Surgery; Stereotactic radiotherapy; STEREOTACTIC-BODY-RADIOTHERAPY; ABLATIVE RADIATION-THERAPY; LOCATED EARLY-STAGE; QUALITY-OF-LIFE; PHASE-II; COLORECTAL-CANCER; PULMONARY OLIGOMETASTASES; MULTICENTER PHASE-2; PROGNOSTIC-FACTORS; DOSE-ESCALATION;

D O I：

10.1016/j.canrad.2023.06.030

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In recent years, the development of both medical imaging and new systemic agents (targeted therapy and immunotherapy) have revolutionized the field of oncology, leading to a new entity: oligometastatic disease. Adding local treatment of oligometastases to systemic treatment could lead to prolonged survival with no significant impact on quality of life. Given the high prevalence of lung oligometastases and the new systemic agents coming with increased pulmonary toxicity, this article provides a comprehensive review of the current state-of-art for radiotherapy of lung oligometastases. After reviewing pretreatment workup, the authors define several radiotherapy regimen based on the localization and size of the oligometastases. A comment on the synergistic combination of medical treatment and radiotherapy is also made, projecting on future steps in this specific clinical setting. (c) 2023 Socie ' te ' franc, aise de radiothe ' rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：36 / 48

页数：13

共 50 条

[31] The role of local therapy in the management of lung and liver oligometastases
Lo, Simon S.
Moffatt-Bruce, Susan D.
Dawson, Laura A.
Schwarz, Roderich E.
Teh, Bin S.
Mayr, Nina A.
Lu, Jiade J.
Grecula, John C.
Olencki, Thomas E.
Timmerman, Robert D.
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (07) : 405 - 416
[32] Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
Yamamoto, Takaya
Niibe, Yuzuru
Aoki, Masahiko
Shintani, Takashi
Yamada, Kazunari
Kobayashi, Mitsuru
Yamashita, Hideomi
Ozaki, Masatoki
Manabe, Yoshihiko
Onishi, Hiroshi
Yahara, Katsuya
Nishikawa, Atsushi
Katsui, Kuniaki
Oh, Ryoong-Jin
Terahara, Atsuro
Jingu, Keiichi
BMC CANCER, 2020, 20 (01)
[33] The Management of Oligometastases in Non-small Cell Lung Cancer- is Stereotactic Ablative Radiotherapy now Standard of Care?
Ratnakumaran, R.
McDonald, F.
CLINICAL ONCOLOGY, 2022, 34 (11) : 753 - 760
[34] The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis
Jeong, Jae-Uk
Rim, Chai Hong
Yoo, Gyu Sang
Cho, Won Kyung
Chie, Eui Kyu
Ahn, Yong Chan
Lee, Jong Hoon
CANCER RESEARCH AND TREATMENT, 2024, 56 (03): : 809 - 824
[35] Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from lung cancer
Manon Kissel
Isabelle Martel-Lafay
Justine Lequesne
Jean-Christophe Faivre
Cécile Le Péchoux
Dinu Stefan
Victor Barraux
Cédric Loiseau
Jean-Michel Grellard
Serge Danhier
Delphine Lerouge
Christos Chouaid
Radj Gervais
Juliette Thariat
BMC Cancer, 19
[36] The Management of Non-Small Cell Lung Cancer With Oligometastases
Downey, Robert J.
THORACIC SURGERY CLINICS, 2014, 24 (04) : 391 - +
[37] Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases?
Li, Shuangjiang
Nie, Shihong
Li, Zhiping
Che, Guowei
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2019, 29 (04) : 544 - 550
[38] Stereotactic Radiotherapy for Ultra-Central Lung Oligometastases in Non-Small-Cell Lung Cancer
Loi, Mauro
Franceschini, Davide
Dominici, Luca
Franzese, Ciro
Chiola, Ilaria
Comito, Tiziana
Marzo, Marco
Reggiori, Giacomo
Mancosu, Pietro
Tomatis, Stefano
Nuyttens, Joost
Scorsetti, Marta
CANCERS, 2020, 12 (04)
[39] Stereotactic body radiotherapy for early stage lung cancer: History and updated role
Ricardi, Umberto
Badellino, Serena
Filippi, Andrea Riccardo
LUNG CANCER, 2015, 90 (03) : 388 - 396
[40] Radiotherapy in the management of synchronous metastatic lung cancer
Khalifa, J.
Levy, A.
Sauvage, L. -M.
Thureau, S.
Darreon, J.
Le Pechoux, C.
Lerouge, D.
Pourel, N.
Antoni, D.
Blais, E.
Martin, E.
Marguerit, A.
Giraud, P.
Riet, F. -G.
CANCER RADIOTHERAPIE, 2024, 28 (01): : 22 - 35

← 1 2 3 4 5 →